logo

For the Inventor, By the Inventor

Noda, Japan

Takayuki Yamazaki

This inventor holds 13 USPTO granted patents and 1 EPO patent. Top assignee: Toyo Suisan Kaisha, Ltd.. Active years: 2002-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takayuki Yamazaki. Retrieved from https://idiyas.com/inventor/takayuki-yamazaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 30.8


Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Noda, JP (2002 - 2008)
  • Yokohama, JP (2011)

Company Filing History:

goldMedal13 out of 25 
 
Toyo Suisan Kaisha, Ltd.
 patents

Years Active: 2002-2011

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 7973145 - Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same (2011-07-05),
2. 7378398 - Method for treating cancer (2008-05-27),
3. 7268209 - Peptides, derivates thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient (2007-09-11),
4. 7148200 - Method for treating cancer (2006-12-12),
5. 6919316 - Immunosuppressive agent (2005-07-19),
6. 6770629 - Administration of a sulfopyranosylacylglycerol to treat certain cancers (2004-08-03),
7. 6759522 - Sulforhamnosylacyglycerol derivatives and use thereof as medicaments (2004-07-06),
8. 6740640 - Sulfofucosylacylglycerol derivatives and administration thereof as medicaments (2004-05-25),
9. 6670361 - Method of treating cancer (2003-12-30),
10. 6518410 - Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments (2003-02-11),
11. 6518248 - Method of treating gastric or colon cancer by administration of a sulfoquinovosylacylglycerol ester (2003-02-11),
12. 6444795 - 1-0-(2-propenyl)-6-0-sulfonylpyranosides (2002-09-03),
13. 6395886 - 1-O-(2-propenyl)-6-deoxy-6-carbonylthiopyranosides (2002-05-28),

Title: **Takayuki Yamazaki: Innovator in Pharmaceutical Chemistry**

Introduction

Takayuki Yamazaki, a prominent inventor based in Noda, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 13 patents, his work focuses on novel compounds for medical applications, showcasing his dedication to advancing health care solutions.

Latest Patents

Among his latest innovations are patents relating to sulfonated sugar compounds and pharmaceutical compositions that utilize these compounds for effective tumor treatment. One notable invention involves sulfoquinovosylacyl propanediol compounds, which have been shown to be effective against tumors. These compounds are characterized by unique molecular structures that allow them to interact effectively within biological systems. Additionally, he has developed methods for treating adenocarcinoma—excluding colon, lung, and gastric cancers—through the administration of specific sulfoquinovosylacylglycerol compounds, further emphasizing his role in targeting challenging cancer forms.

Career Highlights

Yamazaki currently works for Toyo Suisan Kaisha, Ltd., where he engages in research and development aimed at discovering new pharmaceutical treatments. His contributions have had a profound impact on the pharmaceutical industry, particularly in the realm of oncology. His innovative techniques and thorough understanding of chemical compounds continue to pave the way for new therapeutic strategies.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues, including Fumio Sugawara and Kazuyoshi Masaki. These partnerships have been instrumental in fostering a collaborative environment that encourages the exchange of ideas and enhances research efforts, ultimately leading to breakthroughs in pharmaceutical innovations.

Conclusion

Takayuki Yamazaki's work exemplifies the spirit of innovation and dedication in the pursuit of medical advancements. His numerous patents and collaborative projects highlight his commitment to improving health outcomes through targeted pharmaceutical solutions. As research continues to evolve, the contributions of inventors like Yamazaki will undoubtedly play a crucial role in shaping the future of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…